Journal of Child Neurology · 2010 · 13 citations · 11 references
MedicineCancer BiologyOncologyNeoplasiaNeuro-oncologyPediatric OncologyBrain TumorsCancer ProgressionMalignant NeoplasmsMalignant TumorsPediatric Brain TumorsPediatric TumorsApoptosis RegulatorsEpendymoma PathologyImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingPrimary Brain NeoplasmsTherapeutic Target Identification
Intracranial ependymomas are the third most common primary brain tumor in children. We set out to investigate the expression of p-53, p-27, bcl-2, and epidermal growth factor receptor in 13 pediatric infratentorial ependymomas, in correlation with Ki-67/ MIB-1 proliferation index and prognosis. The median progression-free survival was 37.5 months, and the 5-year overall survival was 50%. There was a statistically significant higher expression of Ki-67 and p-53 index in anaplastic tumors. There was also a higher expression of p-27, bcl-2, and epidermal growth factor receptor in anaplastic tumors, but the difference was not statistical significant. No significant correlation was found between overall survival and level of expression of Ki-67, p-53, p-27, bcl-2, and epidermal growth factor receptor. Epidermal growth factor receptor detection in a considerable number of ependymomas probably reflects its role in the neoplastic transformation and can serve as a therapeutic target.
11